USE OF A TRIOXOPYRIMIDINE FOR THE TREATMENT AND PREVENTION OF OCULAR PATHOLOGIC ANGIOGENESIS

摘要

The invention provides the use of trioxopyrimidine compound having an inhibitory activity against MMP-1, MMP-2, MMP-3, MMP-9 and MMP-14 defined as a) IC50 value of less 5 µM for MMP-2, MMP-9 and MMP-14 each; b) a ratio of more than 100 for the IC50 values of MMP-1:MMP-2, MMP-1: MMP-9, MMP-1:MMP-14 and c) a ratio of more than 10 for the IC50 values of MMP-3:MMP-2, MMP-3: MMP-9 MMP-3:MMP-14, for the manufacturing of a medicament for the treatment or prevention of ocular pathologic angiogenesis.